Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MOLECULAR-WEIGHT HEPARIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1842 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bittl, JA
      Editorial comment - From confusion to clarity: Direct thrombin inhibitors for patients with heparin-induced thrombocytopenia

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    2. Greer, IA; Thomson, AJ
      Management of venous thromboembolism in pregnancy

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    3. Alpert, JS; Budaj, AJ; Gurfinkel, EP; Henry, TD
      Issues in antithrombin therapy for UA/NSTEMI

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    4. Lopez-Sendon, J
      Coronary reperfusion in the clinical setting: antithrombotic support to thrombolysis in the coronary care unit

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    5. Ellison, J; Thomson, AJ; Walker, ID; Greer, IA
      Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    6. Lepercq, J; Conard, J; Borel-Derlon, A; Darmon, JY; Boudignat, O; Francoual, C; Priollet, P; Cohen, C; Yvelin, N; Schved, JF; Tournaire, M; Borg, JY
      Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    7. Samama, CM
      Venous thromboembolism deserves your attention

      CRITICAL CARE
    8. Cook, D; McMullin, J; Hodder, R; Heule, M; Pinilla, J; Dodek, P; Stewart, T
      Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey

      CRITICAL CARE
    9. De Lorenzo, F; Noorani, A; Kakkar, VV
      Current trends in the management of thromboembolic events

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    10. Burger, T; Tautenhahn, J; Bock, M; Fahlke, J; Halloul, Z; Lippert, H
      Can a coated Dacron vascular graft maintain a heparin-induced thrombocytopenia type II?

      LANGENBECKS ARCHIVES OF SURGERY
    11. Lockwood, CJ
      Inherited thrombophilias in pregnant patients

      PRENATAL AND NEONATAL MEDICINE
    12. Bell, GK; Goldhaber, SZ
      Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement

      VASCULAR MEDICINE
    13. Hanania, G
      Management of anticoagulants during pregnancy

      HEART
    14. Riedel, M
      Acute pulmonary embolism 2: treatment

      HEART

    15. Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation

      HEART
    16. Glueck, CJ; Freiberg, RA; Fontaine, RN; Sieve-Smith, L; Wang, P
      Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    17. Nicholson, CD; Lensing, AWA
      Old antithrombotics: ready to retire?

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    18. Steinmetzer, T; Hauptmann, J; Sturzebecher, J
      Advances in the development of thrombin inhibitors

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    19. Kaiser, B; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    20. Campbell, SE; Walker, AE; Grimshaw, JM; Campbell, MK; Lowe, GDO; Harper, D; Fowkes, FGR; Petrie, JC
      The prevalence of prophylaxis for deep vein thrombosis in acute hospital trusts

      INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE
    21. Attanasio, E; Russo, P; Carunchio, G; Caprino, L
      Dermatan sulfate versus unfractionated heparin for the prevention of venous thromboembolism in patients undergoing surgery for cancer - A cost-effectiveness analysis

      PHARMACOECONOMICS
    22. Camci, C; Sari, R; Sevinc, A; Buyukberber, S
      Dacarbazine-induced carotid artery and deep venous thrombosis in a patientwith leiomyosarcoma: Case report

      JOURNAL OF CHEMOTHERAPY
    23. Otero, R; Uresandi, F; Cayuela, A; Blanquer, J; Cabezudo, MA; De Gregorio, MA; Lobo, JL; Nauffal, D; Oribe, M
      Use of venous thromboembolism prophylaxis for surgical patients: A multicentre analysis of practice in Spain

      EUROPEAN JOURNAL OF SURGERY
    24. Spyropoulos, AC
      The use of a protocol for the treatment of deep vein thrombosis

      AMERICAN JOURNAL OF MANAGED CARE
    25. Deitcher, SR
      Heparin-induced thrombocytopenia: Pathogenesis, management, and prevention

      FORMULARY
    26. Edelsberg, J; Ollendorf, D; Oster, G
      Venous thromboembolism following major orthopedic surgery: Review of epidemiology and economics

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    27. Cheng, JWM
      Recognition, pathophysiology, and management of acute myocardial infarction

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    28. Fossler, MJ; Barrett, JS; Hainer, JW; Riddle, JG; Ostegaard, P; van der Elst, E; Sprogel, P
      Pharmacodynamics of intravenous and subcutaneous tinzaparin and heparin inhealthy volunteers

      AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
    29. Logason, K; Bergqvist, D
      Low molecular weight heparin (enoxaparin) versus dextran in the preventionof early occlusion following arterial bypass surgery distal to the groin

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    30. Kher, A; Samama, MM
      Low-molecular-weight heparins: Weeks or months instead of days of treatment

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    31. Van Aken, H; Bode, C; Darius, H; Diehm, C; Encke, M; Gulba, DC; Haas, S; Hacke, W; Puhl, W; Quante, M; Riess, H; Scharf, R; Schellong, S; Schror, K; Schulte, KL; Tebbe, U
      Anticoagulation: The present and future

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    32. Cella, G; Sbarai, A; Mazzaro, G; Motta, G; Carraro, P; Andreozzi, GM; Hoppensteadt, DA; Fareed, J
      Tissue factor pathway inhibitor release induced by defibrotide and heparins

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    33. Demir, M; Iqbal, O; Hoppensteadt, DA; Piccolo, P; Ahmad, S; Schultz, CL; Linhardt, RJ; Fareed, J
      Anticoagulant and antiprotease profiles of a novel natural heparinomimeticmannopentaose phosphate sulfate (PI-88)

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    34. Hakki, SI; Fareed, J; Hoppensteadt, DA; Abdullah, H; Camblin, J; Nasseri, AF; Hamadeh, O; Wright, T
      Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery (vol 6, pg 206, 2000)

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    35. Girard, P; Decousus, M; Laporte, S; Buchmuller, A; Herve, P; Lamer, C; Parent, F; Tardy, B
      Diagnosis of pulmonary embolism in patients with proximal deep vein thrombosis - Specificity of symptoms and perfusion defects at baseline and duringanticoagulant therapy

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    36. Axelrod, DA; Wakefield, TW
      Future directions in antithrombotic therapy: Emphasis on venous thromboembolism

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    37. Norwood, SH; McAuley, CE; Berne, JD; Vallina, VL; Kerns, DB; Grahm, TW; McLarty, JW
      A potentially expanded role for enoxaparin in preventing venous thromboembolism in high risk blunt trauma patients

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    38. Hendel, RC
      Acute myocardial ischemia and infarction: Making the right decisions in antithrombotic and reperfusion therapies

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    39. Kupferminc, MJ; Fait, G; Many, A; Lessing, JB; Yair, D; Bar-Am, A; Eldor, A
      Low-molecular-weight heparin for the prevention of obstetric complicationsin women with thrombophilias

      HYPERTENSION IN PREGNANCY
    40. Tinmouth, AH; Morrow, BH; Cruickshank, MK; Moore, PM; Kovacs, MJ
      Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis

      ANNALS OF PHARMACOTHERAPY
    41. Spinler, SA; Hilleman, DE; Cheng, JWM; Howard, PA; Mauro, VF; Lopez, LM; Munger, MA; Gardner, SF; Nappi, JM
      New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines

      ANNALS OF PHARMACOTHERAPY
    42. Willan, AR; O'Brien, BJ
      Cost prediction models for the comparison of two groups

      HEALTH ECONOMICS
    43. Lopshire, JC; Darroca, AG; Gradus-Pizlo, I; O'Donnell, JA
      Treatment of vascular thrombosis with enoxaparin in orthotopic heart transplant patients during the early postoperative period

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    44. Greer, IA
      The acute management of venous thromboembolism in pregnancy

      CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
    45. Berge, E; Fjaertoft, H; Indredavik, B; Sandset, PM
      Validity and reliability of simple questions in assessing short- and long-term outcome in Norwegian stroke patients

      CEREBROVASCULAR DISEASES
    46. Money, SR; York, JW
      Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis

      CARDIOVASCULAR SURGERY
    47. Ruiz-Irastorza, G; Khamashta, MA; Nelson-Piercy, C; Hughes, GRV
      Lupus pregnancy: is heparin a risk factor for osteoporosis?

      LUPUS
    48. Ruiz-Irastorza, G; Khamashta, MA; Hughes, GRV
      Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome

      LUPUS
    49. Vinson, DR
      Eligibility criteria for home treatment of DVT vary

      BRITISH MEDICAL JOURNAL
    50. Eikelboom, J; Baker, R
      Routine home treatment of deep vein thrombosis - Is now a reality

      BRITISH MEDICAL JOURNAL
    51. Schwarz, T; Schmidt, B; Beyer, J; Schellong, SM
      Therapy of isolated calf muscle vein thrombosis with low-molecular-weight heparin

      BLOOD COAGULATION & FIBRINOLYSIS
    52. Miyake, Y; Yokota, K; Fujishima, Y; Sukamoto, T
      The effects of danaparoid, dalteparin and heparin on tissue factor-inducedexperimental disseminated intravascular coagulation and bleeding time in the rat

      BLOOD COAGULATION & FIBRINOLYSIS
    53. Bendz, B; Sevre, K; Andersen, TO; Sandset, PM
      Low molecular weight heparin prevents activation of coagulation in a hypobaric environment

      BLOOD COAGULATION & FIBRINOLYSIS
    54. Harrison, SJ; Rafferty, I; McColl, MD
      Management of heparin allergy during pregnancy with danaparoid

      BLOOD COAGULATION & FIBRINOLYSIS
    55. Storey, RF
      The P2Y(12) receptor as a therapeutic target in cardiovascular disease

      PLATELETS
    56. Wu, CL
      Regional anesthesia and anticoagulation

      JOURNAL OF CLINICAL ANESTHESIA
    57. Szczesny, G; Veihelmann, A; Nolte, D; Olszewski, WL; Messmer, K
      Heparin protects local skin microcirculation in 210 minutes-long intravital microscopy observations under general anaesthesia

      EUROPEAN JOURNAL OF MEDICAL RESEARCH
    58. Malhotra, S; Bhargava, VK; Grover, A; Pandhi, P; Sharma, YP
      A randomized trial to compare the efficacy, safety, cost and platelet aggregation effects of enoxaparin and unfractionated heparin (the ESCAPEU trial)

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    59. Barrett, JS; Gibiansky, E; Hull, RD; Planes, A; Pentikis, H; Hainer, JW; Hua, TA; Gastonguay, M
      Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    60. Martin, M
      Treatment of deep vein thrombosis - a still unresolved problem

      PHLEBOLOGIE
    61. Schimmelpfennig, L
      Acetylsalicylic acid in venous diseases

      PHLEBOLOGIE
    62. Sagedal, S; Hartmann, A; Sundstrom, K; Bjornsen, S; Brosstad, F
      Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    63. Weitz, JI
      New anticoagulant drugs

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    64. Eldor, A
      Thrombophilia and its treatment in pregnancy

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    65. Heit, JA
      Perioperative management of the chronically anticoagulated patient

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    66. Choo, JK; Kereiakes, DJ
      Low molecular weight heparin therapy for percutaneous coronary intervention: A practice in evolution

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    67. Andreescu, ACM; Cushman, M; Hammond, JM; Wood, ME
      Trousseau's syndrome treated with long-term subcutaneous lepirudin (case report and review of the literature)

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    68. Weimann, G; Lubenow, N; Selleng, K; Eichler, P; Albrecht, D; Greinacher, A
      Glucosamine sulfate does not crossreact with the antibodies of patients with heparin-induced thrombocytopenia

      EUROPEAN JOURNAL OF HAEMATOLOGY
    69. Krotenberg, R; Adler, U; Pomeranz, B; Miller, JD; Russell, MW
      Dalteparin vs. enoxaparin as prophylaxis for deep-vein thrombosis after total hip or knee arthroplasty - A retrospective analysis

      AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION
    70. Shehata, HA; Nelson-Piercy, C; Khamashta, MA
      Management of pregnancy in antiphospholipid syndrome

      RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
    71. Gelinas, JP; Stoddart, LV; Snyder, EL
      Thrombocytopenia and critical care medicine

      JOURNAL OF INTENSIVE CARE MEDICINE
    72. Brookenthal, KR; Freedman, KB; Lotke, PA; Fitzgerald, RH; Lonner, JH
      A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty

      JOURNAL OF ARTHROPLASTY
    73. Drolet, P; Girard, M
      Neuraxial locoregional anesthesia and vascular surgery: The advantages

      CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE
    74. Samama, CM; Baillard, C
      Neuraxial locoregional anesthesia should no longer be used in vascular surgery

      CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE
    75. Fitchett, D; Goodman, S; Langer, A
      New advances in the management of acute coronary syndromes: 1. Matching treatment to risk

      CANADIAN MEDICAL ASSOCIATION JOURNAL
    76. Leys, D
      Treatment for cerebral ischemia

      PRESSE MEDICALE
    77. Mahe, I
      Subcutaneous enoxaparin once or twice daily compared with intravenous infractioned heparin for treatment of venous thromboembolic disease

      PRESSE MEDICALE
    78. Gentric, A; Couturaud, F; Mottier, D
      Anticoagulants in the elderly - Indications

      PRESSE MEDICALE
    79. Wirth, T; Schneider, B; Misselwitz, F; Lomb, M; Tuylu, H; Egbring, R; Griss, P
      Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): Results of a randomized controlled trial

      ARTHROSCOPY
    80. Kelly, RF
      New developments in percutaneous coronary intervention

      CRITICAL CARE CLINICS
    81. Sundrani, R; Klein, LW
      Antithrombotic and thrombolytic therapy in acute cardiac care

      CRITICAL CARE CLINICS
    82. Heit, JA
      Prevention of venous thromboembolism

      CLINICS IN GERIATRIC MEDICINE
    83. Berman, AR
      Pulmonary embolism in the elderly

      CLINICS IN GERIATRIC MEDICINE
    84. Schwarcz, TH; Quick, RC; Minion, DJ; Kearney, PA; Kwolek, CJ; Endean, ED
      Enoxaparin treatment in high-risk trauma patients limits the utility of surveillance venous duplex scanning

      JOURNAL OF VASCULAR SURGERY
    85. AbuRahma, AF; Mullins, DA
      Endovascular caval interruption in pregnant patients with deep vein thrombosis of the lower extremity

      JOURNAL OF VASCULAR SURGERY
    86. Burg, MD; Dallara, JJ
      Rupture of a previously normal spleen in association with enoxaparin: An unusual cause of shock

      JOURNAL OF EMERGENCY MEDICINE
    87. Hodl, R; Huber, K; Kraxner, W; Klein, W
      Limitation of vWf meta-analysis in LMWH comparison

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    88. Edlow, JA
      Emergency department management of pulmonary embolism

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    89. Shannon, AW; Harrigan, RA
      General pharmacologic treatment of acute myocardial infarction

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    90. Llinas, R; Caplan, LR
      Evidence-based treatment of patients with ischemic cerebrovascular disease

      NEUROLOGIC CLINICS
    91. Mitragotri, S; Kost, J
      Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound

      PHARMACEUTICAL RESEARCH
    92. Thanou, M; Verhoef, JC; Nihot, MT; Verheijden, JHM; Junginger, HE
      Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using Carbopol (R) 934P

      PHARMACEUTICAL RESEARCH
    93. O'Shaughnessy, AM; Fitzgerald, DE
      An audit of the clinical and sub-clinical changes in the first year following an acute, deep vein thrombosis

      INTERNATIONAL ANGIOLOGY
    94. Neagu, M; Manda, G; Constantin, C; Tanaseanu, C; Mikhailidis, DP
      The in vitro effect of a low molecular weight heparin, nadroparin (Fraxiparine), on leukocytes obtained from patients with vascular disease

      INTERNATIONAL ANGIOLOGY
    95. Nicolaides, AN; Breddin, HK; Fareed, J; Goldhaber, S; Haas, S; Hull, R; Kalodiki, E; Myers, K; Samama, M; Sasahara, A
      Prevention of venous thromboembolism - International Consensus Statement -Guidelines compiled in accordance with the scientific evidence

      INTERNATIONAL ANGIOLOGY
    96. Lai, KN; Ho, K; Cheung, RCK; Lit, LCW; Lee, SKM; Fung, KS; Tong, MKL; Lam, CWK
      Effect of low molecular weight heparin on bone metabolism and hyperlipidemia in patients on maintenance hemodialysis

      INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
    97. Vila, V; Martinez-Sales, V; Reganon, E; Peris, E; Perez, F; Ruano, M; Aznar, J
      Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes

      HAEMATOLOGICA
    98. Momi, S; Nasimi, M; Colucci, M; Nenci, GP; Gresele, P
      Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition

      HAEMATOLOGICA
    99. Blanc-Brude, OP; Chambers, RC; Leoni, P; Dik, WA; Laurent, GJ
      Factor Xa is a fibroblast mitogen via binding to effector-cell protease receptor-1 and autocrine release of PDGF

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    100. Grau, E; Tenias, JM; Real, E; Medrano, J; Ferrer, R; Pastor, E; Selfa, S
      Home treatment of deep venous thrombosis with low molecular weight heparin: Long-term incidence of recurrent venous thromboembolism

      AMERICAN JOURNAL OF HEMATOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 22:10:49